| 1 |
Fajardo LF, Colby TV. Pathogenesis of neo-occlusive liver disease after radiation[J]. Arch Pathol Lab Med, 1980,104(11): 584-588.
|
| 2 |
Willmot FC, Robertson GW. Senecio disease, or cirrhosis of the liver due to senecio poisoning[J]. Lancet, 1920,2: 848-849.
|
| 3 |
Bras G, Jeliffe DB, Stuart KL. Veno-occlusive disease of the liver with non-portal type of cirrhosis occurring in Jamaica[J]. Arch Pathol, 1954,57(4): 285-300.
|
| 4 |
Shulman HM, Fisher LB, Schoch HG, et al. Venocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms[J]. Hepatology, 1994,19(5): 1171-1180.
|
| 5 |
Helmy A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome[J]. Aliment Pharmacol Ther, 2006,23(1): 11-25.
|
| 6 |
Mohabbat O, Younos MS, Merzad AA, et al. An outbreak of hepatic veno-occlusive disease in north-western Afghanistan[J]. Lancet, 1976,2(7980): 269-271.
|
| 7 |
Stegelmeier BL, Edgar JA, Colegate SM, et al. Pyrrolizidine alkaloid plants, metabolism and toxicity[J]. J Nat Toxins, 1999,8(1): 95-116.
|
| 8 |
Huxtable RJ. Human health implication of pyrrolizidine alkaloids and herbs containing them//Cheeke PR. Toxicants of plant origins[M]. Boca Raton, FL: CRC Press Inc, 2001:41-79.
|
| 9 |
Fu PP, Xia QS, Lin G, et al. Pyrrolizidine alkaloids-genotoxicity,metabolism enzymes, metabolic activation, and mechanisms[J]. Drug Metab Rev, 2004,36(1): 1-55.
|
| 10 |
Zuckerman M, Steenkamp V, Stewar MJ. Hepatic veno-occlusive disease as a result of traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique[J]. J Clin Pathol,2002,55(9): 676-679.
|
| 11 |
Stickel F, Egerer G, Seitz HK. Hepatotoxicity of botanicals. Public Health Nutrition, 2000,3(2): 113-124.
|
| 12 |
Yuan SQ, Gu GM, Wei TT. Studies on the alkaloids of Gynura segetum (Lour.) Merr[J]. Yaoxue Xuebao, 1990,25(3): 191-197
|
| 13 |
Ge L, Ji Yao W, Na L, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum[J]. Journal of Hepatology, 2011,54(4): 666-673.
|
| 14 |
Wadleigh M, Ho V, Momtaz P, et al. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment[J]. Curr Opin Hematol, 2003,10(6): 451-462.
|
| 15 |
Faioni EM, Mannucci PM. Venocclusive disease of the liver after bone marrow transplantation: the role of hemostasis[J]. Leuk Lymphoma, 1997,25(3-4): 233-245.
|
| 16 |
Strasser SI, McDonald SJ, Schoch HG, et al. Severe hepatocellular injury after hematopoietic cell transplant: incidence and etiology in 2136 consecutive patients [Abstract] [J]. Hepatology, 2000,32: 299.
|
| 17 |
Tanikawa S, Mori S, Ohhashi K, et al. Predictive markers for hepatic venoocclusive venoocclusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study[J]. Bone Marrow Transplant, 2000,26(8): 881-886.
|
| 18 |
Nicolau C, Bru C, Carreras E, et al. Sonographic diagnosis and hemodynamic correlation in veno-occlusive disease of the liver[J]. J Ultras Med, 1993,12(8): 437-440.
|
| 19 |
Erturk SM, Mortele J, Bink ert CA, et al. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transp lantation[J]. AJR Am J Roentgenol, 2006,186(6): 1497-1501.
|
| 20 |
DeLeve LD, McCuskey RS, Wang X, et al. Characterization of a reproducible rat model of hepatic veno-occlusive disease[J]. Hepatology, 1999,29(6): 1779-1791.
|
| 21 |
Shulman HM, Fisher LB, Schoch HG, et al. Veno-occlusive disease of the liver after marrow transplantation: histologic correlates of clinical signs and symptoms[J]. Hepatology, 1994,19(5): 1171-1180.
|
| 22 |
Mortelé KJ, Van Vlierberghe H, Wiesner W, et al. Hepatic veno-occlusive disease: MRI findings[J]. Abdom imaging, 2002,27(5): 523-526.
|
| 23 |
Lee JL, Gooley T, Bensinger W, et al. Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome[J]. Biol Blood Marrow Transplant, 1999,5(5): 306-315.
|
| 24 |
Laurie D, Howard S, George M. Toxic injury to hepatic sinusoids:sinusoidal obstruction syndrome(veno-occlusive disease)[J]. Semin Liver Dis, 2002,22(1): 27-41.
|
| 25 |
Chopra R, Eaton JD, Grassi A, et al. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study[J]. Br J Haematol, 2000,111(4): 1122-1129.
|
| 26 |
Zhe C, Ji-Rong H. Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations[J]. Neth J Med, 2010,68(6): 252-260.
|
| 27 |
Khoury H, Adkins D, Brown R, et al. Does early treatment with high-dose methylprednisolone alter the course of hepatic regimenrelated toxicity[J]. Bone Marrow Transplant, 2000,25(7): 737-743.
|